Summary

The global Biologics CMO (Contract Manufacturing Organization) Services market size is predicted to grow from US$ 27254 million in 2025 to US$ 49875 million in 2032; it is expected to grow at a CAGR of 9.0% from 2026 to 2032.
Biologics CMO (Contract Manufacturing Organization) Services refer to manufacturing services provided by contract manufacturing organizations under client agreements to biopharmaceutical companies, pharmaceutical companies, and other drug development organizations. These services primarily include biologic drug substance manufacturing, drug product manufacturing, aseptic fill-finish, and other GMP manufacturing activities. The service scope covers antibodies, vaccines, cell and gene therapies, and other biologics, and may support both clinical-stage and commercial-stage production. The market includes contract manufacturing services provided by independent third-party CMOs as well as external manufacturing services offered by in-house CMO business units of pharmaceutical and biopharmaceutical companies. Compared with CDMO services, CMO services are primarily focused on manufacturing execution and production capabilities and generally do not emphasize early-stage drug development, comprehensive process development, formulation development, or other R&D-intensive activities.
Biologics CMO (Contract Manufacturing Organization) services refer to GMP manufacturing services provided under contract to pharmaceutical companies, biotechnology companies, and other drug development organizations. These services primarily cover biologic drug substance (DS) manufacturing, drug product (DP) manufacturing, aseptic fill-finish, packaging, and related quality control activities. By provider type, the industry includes both independent CMOs whose core business is third-party contract manufacturing and in-house CMO business units of large pharmaceutical and biopharmaceutical companies that provide manufacturing capacity to external customers. Compared with CDMOs, CMOs place greater emphasis on process execution following technology transfer, scale-up manufacturing, quality control, and reliable supply, while early-stage drug discovery, systematic process development, and formulation development are generally not their primary functions.
By product type, biologics CMO services mainly cover antibodies, vaccines, cell and gene therapies, and other biologics. Antibodies represent one of the more mature contract manufacturing segments and typically involve mammalian cell culture, harvest, chromatography purification, viral clearance, and drug substance preparation. Vaccine manufacturing involves a wider range of production platforms and process technologies. Cell and gene therapies generally feature smaller batch sizes, more complex processes, stringent quality requirements, and highly customized manufacturing workflows. Consequently, facility design, equipment configuration, biosafety requirements, and quality systems vary significantly across different biologic modalities.
By manufacturing stage, the industry can be divided into biologic drug substance manufacturing and biologic drug product manufacturing. Drug substance manufacturing is generally the more technology- and capital-intensive segment and includes cell culture or microbial fermentation, separation, purification, and bulk drug substance storage. Drug product manufacturing primarily covers formulation, aseptic filling, lyophilization, and filling into vials, prefilled syringes, or cartridges. Some large CMOs have established integrated DS-to-DP manufacturing networks, while other specialized providers focus on large-scale drug substance manufacturing or specific activities such as sterile fill-finish.
Direct customers primarily include large pharmaceutical and biopharmaceutical companies, small and mid-sized pharmaceutical and biotechnology companies, and other drug development organizations. Large pharmaceutical companies generally maintain internal manufacturing capabilities but may outsource production due to capacity constraints, new product introductions, regional supply requirements, specialized manufacturing needs, or efforts to reduce fixed-asset investment. Small and mid-sized biotechnology companies tend to rely more heavily on external manufacturing resources, with CMOs supporting clinical supply, scale-up, and commercial production.
Biologics CMO is an industry characterized by high capital, technical, and regulatory barriers. Mammalian cell culture is a core platform for antibodies and many recombinant proteins. Commercial manufacturing commonly utilizes individual bioreactors ranging from approximately 2,000 L to 20,000 L, while large-scale commercial facilities typically combine multiple bioreactors into a production train. Effective annual capacity per production line depends on the number of bioreactors, culture cycle, product titer, batch success rate, and facility utilization. Single-use bioreactors offer shorter construction timelines, greater flexibility for product changeover, and lower cross-contamination risk, while large stainless-steel systems continue to provide significant economies of scale for mature, high-volume commercial products.
The upstream supply chain primarily consists of cell culture media, single-use bioprocess consumables, bioreactors, filtration systems, chromatography resins and columns, buffer materials, and sterile packaging components. Critical materials such as culture media, single-use consumables, and high-performance chromatography media can materially affect batch consistency and product quality. Major CMOs therefore typically establish multi-supplier strategies and safety stocks for critical materials while increasing facility utilization through standardized platform processes.
Regulatory compliance and quality systems constitute major competitive barriers. Biologics manufacturing must continuously comply with GMP requirements and maintain robust systems for quality management, data integrity, contamination control, process validation, and batch release. Once a commercial product has received regulatory approval and its manufacturing process has been validated at a specific CMO facility, transferring production to another site generally requires additional technology transfer, validation, and regulatory change procedures. The associated time and cost create relatively high customer stickiness and long contract durations for established commercial products.
Key competitive factors include commercial manufacturing experience, GMP compliance track record, manufacturing scale, capacity utilization, technology transfer efficiency, batch success rates, delivery reliability, and global manufacturing networks. Large CMOs with extensive bioreactor capacity and multiple manufacturing sites are well positioned to serve high-volume commercial antibody products, while mid-sized and specialized CMOs differentiate themselves through flexible capacity, small-batch manufacturing, complex molecule capabilities, or specialized technology platforms.
Profitability varies significantly depending on product type, manufacturing scale, capacity utilization, and development stage. Mature commercial biologics generally provide more stable batch demand and higher equipment utilization, whereas clinical-stage projects involve smaller batch volumes, frequent product changeovers, and greater project attrition. Gross margins for established biologics CMO manufacturing operations can generally fall within approximately 20%–40%. Large-scale antibody drug substance manufacturing can achieve stronger economies of scale at high utilization rates, while cell and gene therapy manufacturing and small-batch sterile fill-finish may command higher unit pricing but also require greater labor, quality control, and facility costs.
Future industry growth will be supported by the continued expansion of biologics pipelines, increasing commercialization of antibody drugs and emerging biologic modalities, efforts by pharmaceutical companies to reduce fixed-asset investment, and deeper specialization across pharmaceutical manufacturing networks. At the same time, major CMOs continue to add large-scale 20,000 L-class mammalian cell culture capacity, resulting in greater capacity availability in certain regions. Competition is therefore expected to gradually shift from pure capacity expansion toward a broader focus on capacity utilization, manufacturing efficiency, quality consistency, supply reliability, and lifecycle manufacturing capabilities.
Report Scope
LPI (LP Information)' newest research report, the “Biologics CMO (Contract Manufacturing Organization) Services Industry Forecast” looks at past sales and reviews total world Biologics CMO (Contract Manufacturing Organization) Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Biologics CMO (Contract Manufacturing Organization) Services sales for 2026 through 2032. With Biologics CMO (Contract Manufacturing Organization) Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologics CMO (Contract Manufacturing Organization) Services industry.
This Insight Report provides a comprehensive analysis of the global Biologics CMO (Contract Manufacturing Organization) Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biologics CMO (Contract Manufacturing Organization) Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biologics CMO (Contract Manufacturing Organization) Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologics CMO (Contract Manufacturing Organization) Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologics CMO (Contract Manufacturing Organization) Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Biologics CMO (Contract Manufacturing Organization) Services market by product type, application, key players and key regions and countries.
Market Segmentation
Segmentation by Type:
Cell and Gene Therapies
Antibodies
Vaccines
Others
Segmentation by CMO Provider Type:
In-house CMO
Independent CMO
Segmentation by Manufacturing Stage:
Drug Substance (DS) Manufacturing
Drug Product (DP) Manufacturing
Segmentation by Application:
Large Pharmaceutical and Biopharmaceutical Companies
Small and Mid-sized Pharmaceutical and Biotechnology Companies
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lonza Group AG
Samsung Biologics Co., Ltd.
FUJIFILM Biotechnologies
Boehringer Ingelheim BioXcellence
WuXi Biologics (Cayman) Inc.
Thermo Fisher Scientific – Patheon Pharma Services
Catalent, Inc.
AGC Biologics
National Resilience, Inc.
Vetter Pharma International GmbH
Rentschler Biopharma SE
KBI Biopharma, Inc.
LOTTE BIOLOGICS Co., Ltd.
Pfizer CentreOne
AbbVie Contract Manufacturing
Syngene International Limited
Avid Bioservices, Inc.
Recipharm Advanced Bio
Ajinomoto Bio-Pharma Services
Wacker Biotech GmbH
Bora Biologics
3PBIOVIAN
Fareva
Aenova Group
Siegfried Holding AG
GenScript ProBio
Chime Biologics (Wuhan) Co., Ltd.
MabPlex International
Pharmaron Beijing Co., Ltd.
Thousand Oaks Biologics Inc.
Cytovance Biologics, Inc.
Porton Pharma Solutions Ltd.

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biologics CMO (Contract Manufacturing Organization) Services Market Size (2021-2032)
2.1.2 Biologics CMO (Contract Manufacturing Organization) Services Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Biologics CMO (Contract Manufacturing Organization) Services by Country/Region (2021, 2025 & 2032)
2.2 Biologics CMO (Contract Manufacturing Organization) Services Segment by Type
2.2.1 Cell and Gene Therapies
2.2.2 Antibodies
2.2.3 Vaccines
2.2.4 Others
2.2.5 Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type
2.2.5.1 Biologics CMO (Contract Manufacturing Organization) Services Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Type (2021-2026)
2.3 Biologics CMO (Contract Manufacturing Organization) Services Segment by CMO Provider Type
2.3.1 In-house CMO
2.3.2 Independent CMO
2.3.3 Biologics CMO (Contract Manufacturing Organization) Services Market Size by CMO Provider Type
2.3.3.1 Biologics CMO (Contract Manufacturing Organization) Services Market Size CAGR by CMO Provider Type (2021 VS 2025 VS 2032)
2.3.3.2 Global Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by CMO Provider Type (2021-2026)
2.4 Biologics CMO (Contract Manufacturing Organization) Services Segment by Manufacturing Stage
2.4.1 Drug Substance (DS) Manufacturing
2.4.2 Drug Product (DP) Manufacturing
2.4.3 Biologics CMO (Contract Manufacturing Organization) Services Market Size by Manufacturing Stage
2.4.3.1 Biologics CMO (Contract Manufacturing Organization) Services Market Size CAGR by Manufacturing Stage (2021 VS 2025 VS 2032)
2.4.3.2 Global Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Manufacturing Stage (2021-2026)
2.5 Biologics CMO (Contract Manufacturing Organization) Services Segment by Application
2.5.1 Large Pharmaceutical and Biopharmaceutical Companies
2.5.2 Small and Mid-sized Pharmaceutical and Biotechnology Companies
2.5.3 Others
2.5.4 Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application
2.5.4.1 Biologics CMO (Contract Manufacturing Organization) Services Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Application (2021-2026)

3 Biologics CMO (Contract Manufacturing Organization) Services Market Size by Player
3.1 Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Player
3.1.1 Global Biologics CMO (Contract Manufacturing Organization) Services Revenue by Player (2021-2026)
3.1.2 Global Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share by Player (2021-2026)
3.2 Global Biologics CMO (Contract Manufacturing Organization) Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Biologics CMO (Contract Manufacturing Organization) Services by Region
4.1 Biologics CMO (Contract Manufacturing Organization) Services Market Size by Region (2021-2026)
4.2 Global Biologics CMO (Contract Manufacturing Organization) Services Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth (2021-2026)
4.4 APAC Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth (2021-2026)
4.5 Europe Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth (2021-2026)
4.6 Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth (2021-2026)

5 Americas
5.1 Americas Biologics CMO (Contract Manufacturing Organization) Services Market Size by Country (2021-2026)
5.2 Americas Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type (2021-2026)
5.3 Americas Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Biologics CMO (Contract Manufacturing Organization) Services Market Size by Region (2021-2026)
6.2 APAC Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type (2021-2026)
6.3 APAC Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Biologics CMO (Contract Manufacturing Organization) Services Market Size by Country (2021-2026)
7.2 Europe Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type (2021-2026)
7.3 Europe Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services by Region (2021-2026)
8.2 Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type (2021-2026)
8.3 Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 Global Biologics CMO (Contract Manufacturing Organization) Services Market Forecast
10.1 Global Biologics CMO (Contract Manufacturing Organization) Services Forecast by Region (2027-2032)
10.1.1 Global Biologics CMO (Contract Manufacturing Organization) Services Forecast by Region (2027-2032)
10.1.2 Americas Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.1.3 APAC Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.1.4 Europe Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.1.5 Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.2 Americas Biologics CMO (Contract Manufacturing Organization) Services Forecast by Country (2027-2032)
10.2.1 United States Market Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.2.2 Canada Market Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.2.3 Mexico Market Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.2.4 Brazil Market Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.3 APAC Biologics CMO (Contract Manufacturing Organization) Services Forecast by Region (2027-2032)
10.3.1 China Biologics CMO (Contract Manufacturing Organization) Services Market Forecast
10.3.2 Japan Market Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.3.3 Korea Market Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.3.4 Southeast Asia Market Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.3.5 India Market Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.3.6 Australia Market Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.4 Europe Biologics CMO (Contract Manufacturing Organization) Services Forecast by Country (2027-2032)
10.4.1 Germany Market Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.4.2 France Market Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.4.3 UK Market Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.4.4 Italy Market Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.4.5 Russia Market Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.5 Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Forecast by Region (2027-2032)
10.5.1 Egypt Market Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.5.2 South Africa Market Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.5.3 Israel Market Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.5.4 Turkey Market Biologics CMO (Contract Manufacturing Organization) Services Forecast
10.6 Global Biologics CMO (Contract Manufacturing Organization) Services Forecast by Type (2027-2032)
10.7 Global Biologics CMO (Contract Manufacturing Organization) Services Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Biologics CMO (Contract Manufacturing Organization) Services Forecast

11 Key Players Analysis
11.1 Lonza Group AG
11.1.1 Lonza Group AG Company Information
11.1.2 Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.1.3 Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lonza Group AG Main Business Overview
11.1.5 Lonza Group AG Latest Developments
11.2 Samsung Biologics Co., Ltd.
11.2.1 Samsung Biologics Co., Ltd. Company Information
11.2.2 Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.2.3 Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Samsung Biologics Co., Ltd. Main Business Overview
11.2.5 Samsung Biologics Co., Ltd. Latest Developments
11.3 FUJIFILM Biotechnologies
11.3.1 FUJIFILM Biotechnologies Company Information
11.3.2 FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.3.3 FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 FUJIFILM Biotechnologies Main Business Overview
11.3.5 FUJIFILM Biotechnologies Latest Developments
11.4 Boehringer Ingelheim BioXcellence
11.4.1 Boehringer Ingelheim BioXcellence Company Information
11.4.2 Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.4.3 Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Boehringer Ingelheim BioXcellence Main Business Overview
11.4.5 Boehringer Ingelheim BioXcellence Latest Developments
11.5 WuXi Biologics (Cayman) Inc.
11.5.1 WuXi Biologics (Cayman) Inc. Company Information
11.5.2 WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.5.3 WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 WuXi Biologics (Cayman) Inc. Main Business Overview
11.5.5 WuXi Biologics (Cayman) Inc. Latest Developments
11.6 Thermo Fisher Scientific – Patheon Pharma Services
11.6.1 Thermo Fisher Scientific – Patheon Pharma Services Company Information
11.6.2 Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.6.3 Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Thermo Fisher Scientific – Patheon Pharma Services Main Business Overview
11.6.5 Thermo Fisher Scientific – Patheon Pharma Services Latest Developments
11.7 Catalent, Inc.
11.7.1 Catalent, Inc. Company Information
11.7.2 Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.7.3 Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Catalent, Inc. Main Business Overview
11.7.5 Catalent, Inc. Latest Developments
11.8 AGC Biologics
11.8.1 AGC Biologics Company Information
11.8.2 AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.8.3 AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 AGC Biologics Main Business Overview
11.8.5 AGC Biologics Latest Developments
11.9 National Resilience, Inc.
11.9.1 National Resilience, Inc. Company Information
11.9.2 National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.9.3 National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 National Resilience, Inc. Main Business Overview
11.9.5 National Resilience, Inc. Latest Developments
11.10 Vetter Pharma International GmbH
11.10.1 Vetter Pharma International GmbH Company Information
11.10.2 Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.10.3 Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Vetter Pharma International GmbH Main Business Overview
11.10.5 Vetter Pharma International GmbH Latest Developments
11.11 Rentschler Biopharma SE
11.11.1 Rentschler Biopharma SE Company Information
11.11.2 Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.11.3 Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Rentschler Biopharma SE Main Business Overview
11.11.5 Rentschler Biopharma SE Latest Developments
11.12 KBI Biopharma, Inc.
11.12.1 KBI Biopharma, Inc. Company Information
11.12.2 KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.12.3 KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 KBI Biopharma, Inc. Main Business Overview
11.12.5 KBI Biopharma, Inc. Latest Developments
11.13 LOTTE BIOLOGICS Co., Ltd.
11.13.1 LOTTE BIOLOGICS Co., Ltd. Company Information
11.13.2 LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.13.3 LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 LOTTE BIOLOGICS Co., Ltd. Main Business Overview
11.13.5 LOTTE BIOLOGICS Co., Ltd. Latest Developments
11.14 Pfizer CentreOne
11.14.1 Pfizer CentreOne Company Information
11.14.2 Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.14.3 Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Pfizer CentreOne Main Business Overview
11.14.5 Pfizer CentreOne Latest Developments
11.15 AbbVie Contract Manufacturing
11.15.1 AbbVie Contract Manufacturing Company Information
11.15.2 AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.15.3 AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 AbbVie Contract Manufacturing Main Business Overview
11.15.5 AbbVie Contract Manufacturing Latest Developments
11.16 Syngene International Limited
11.16.1 Syngene International Limited Company Information
11.16.2 Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.16.3 Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Syngene International Limited Main Business Overview
11.16.5 Syngene International Limited Latest Developments
11.17 Avid Bioservices, Inc.
11.17.1 Avid Bioservices, Inc. Company Information
11.17.2 Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.17.3 Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Avid Bioservices, Inc. Main Business Overview
11.17.5 Avid Bioservices, Inc. Latest Developments
11.18 Recipharm Advanced Bio
11.18.1 Recipharm Advanced Bio Company Information
11.18.2 Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.18.3 Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Recipharm Advanced Bio Main Business Overview
11.18.5 Recipharm Advanced Bio Latest Developments
11.19 Ajinomoto Bio-Pharma Services
11.19.1 Ajinomoto Bio-Pharma Services Company Information
11.19.2 Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.19.3 Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Ajinomoto Bio-Pharma Services Main Business Overview
11.19.5 Ajinomoto Bio-Pharma Services Latest Developments
11.20 Wacker Biotech GmbH
11.20.1 Wacker Biotech GmbH Company Information
11.20.2 Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.20.3 Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Wacker Biotech GmbH Main Business Overview
11.20.5 Wacker Biotech GmbH Latest Developments
11.21 Bora Biologics
11.21.1 Bora Biologics Company Information
11.21.2 Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.21.3 Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Bora Biologics Main Business Overview
11.21.5 Bora Biologics Latest Developments
11.22 3PBIOVIAN
11.22.1 3PBIOVIAN Company Information
11.22.2 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.22.3 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 3PBIOVIAN Main Business Overview
11.22.5 3PBIOVIAN Latest Developments
11.23 Fareva
11.23.1 Fareva Company Information
11.23.2 Fareva Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.23.3 Fareva Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Fareva Main Business Overview
11.23.5 Fareva Latest Developments
11.24 Aenova Group
11.24.1 Aenova Group Company Information
11.24.2 Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.24.3 Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Aenova Group Main Business Overview
11.24.5 Aenova Group Latest Developments
11.25 Siegfried Holding AG
11.25.1 Siegfried Holding AG Company Information
11.25.2 Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.25.3 Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 Siegfried Holding AG Main Business Overview
11.25.5 Siegfried Holding AG Latest Developments
11.26 GenScript ProBio
11.26.1 GenScript ProBio Company Information
11.26.2 GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.26.3 GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 GenScript ProBio Main Business Overview
11.26.5 GenScript ProBio Latest Developments
11.27 Chime Biologics (Wuhan) Co., Ltd.
11.27.1 Chime Biologics (Wuhan) Co., Ltd. Company Information
11.27.2 Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.27.3 Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 Chime Biologics (Wuhan) Co., Ltd. Main Business Overview
11.27.5 Chime Biologics (Wuhan) Co., Ltd. Latest Developments
11.28 MabPlex International
11.28.1 MabPlex International Company Information
11.28.2 MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.28.3 MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.28.4 MabPlex International Main Business Overview
11.28.5 MabPlex International Latest Developments
11.29 Pharmaron Beijing Co., Ltd.
11.29.1 Pharmaron Beijing Co., Ltd. Company Information
11.29.2 Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.29.3 Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.29.4 Pharmaron Beijing Co., Ltd. Main Business Overview
11.29.5 Pharmaron Beijing Co., Ltd. Latest Developments
11.30 Thousand Oaks Biologics Inc.
11.30.1 Thousand Oaks Biologics Inc. Company Information
11.30.2 Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.30.3 Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.30.4 Thousand Oaks Biologics Inc. Main Business Overview
11.30.5 Thousand Oaks Biologics Inc. Latest Developments
11.31 Cytovance Biologics, Inc.
11.31.1 Cytovance Biologics, Inc. Company Information
11.31.2 Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.31.3 Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.31.4 Cytovance Biologics, Inc. Main Business Overview
11.31.5 Cytovance Biologics, Inc. Latest Developments
11.32 Porton Pharma Solutions Ltd.
11.32.1 Porton Pharma Solutions Ltd. Company Information
11.32.2 Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
11.32.3 Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue, Gross Margin and Market Share (2021-2026)
11.32.4 Porton Pharma Solutions Ltd. Main Business Overview
11.32.5 Porton Pharma Solutions Ltd. Latest Developments

12 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Biologics CMO (Contract Manufacturing Organization) Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Biologics CMO (Contract Manufacturing Organization) Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cell and Gene Therapies
Table 4. Major Players of Antibodies
Table 5. Major Players of Vaccines
Table 6. Major Players of Others
Table 7. Biologics CMO (Contract Manufacturing Organization) Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Type (2021-2026)
Table 10. Major Players of In-house CMO
Table 11. Major Players of Independent CMO
Table 12. Biologics CMO (Contract Manufacturing Organization) Services Market Size CAGR by CMO Provider Type (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size by CMO Provider Type (2021-2026) & ($ millions)
Table 14. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by CMO Provider Type (2021-2026)
Table 15. Major Players of Drug Substance (DS) Manufacturing
Table 16. Major Players of Drug Product (DP) Manufacturing
Table 17. Biologics CMO (Contract Manufacturing Organization) Services Market Size CAGR by Manufacturing Stage (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size by Manufacturing Stage (2021-2026) & ($ millions)
Table 19. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Manufacturing Stage (2021-2026)
Table 20. Biologics CMO (Contract Manufacturing Organization) Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application (2021-2026) & ($ millions)
Table 22. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Application (2021-2026)
Table 23. Global Biologics CMO (Contract Manufacturing Organization) Services Revenue by Player (2021-2026) & ($ millions)
Table 24. Global Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share by Player (2021-2026)
Table 25. Biologics CMO (Contract Manufacturing Organization) Services Key Players Head office and Products Offered
Table 26. Biologics CMO (Contract Manufacturing Organization) Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size by Region (2021-2026) & ($ millions)
Table 30. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Region (2021-2026)
Table 31. Global Biologics CMO (Contract Manufacturing Organization) Services Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Biologics CMO (Contract Manufacturing Organization) Services Market Size by Country (2021-2026) & ($ millions)
Table 34. Americas Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Country (2021-2026)
Table 35. Americas Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type (2021-2026) & ($ millions)
Table 36. Americas Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Type (2021-2026)
Table 37. Americas Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application (2021-2026) & ($ millions)
Table 38. Americas Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Application (2021-2026)
Table 39. APAC Biologics CMO (Contract Manufacturing Organization) Services Market Size by Region (2021-2026) & ($ millions)
Table 40. APAC Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Region (2021-2026)
Table 41. APAC Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type (2021-2026) & ($ millions)
Table 42. APAC Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application (2021-2026) & ($ millions)
Table 43. Europe Biologics CMO (Contract Manufacturing Organization) Services Market Size by Country (2021-2026) & ($ millions)
Table 44. Europe Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Country (2021-2026)
Table 45. Europe Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type (2021-2026) & ($ millions)
Table 46. Europe Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application (2021-2026) & ($ millions)
Table 47. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Market Size by Region (2021-2026) & ($ millions)
Table 48. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Market Size by Type (2021-2026) & ($ millions)
Table 49. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Market Size by Application (2021-2026) & ($ millions)
Table 50. Key Market Drivers & Growth Opportunities of Biologics CMO (Contract Manufacturing Organization) Services
Table 51. Key Market Challenges & Risks of Biologics CMO (Contract Manufacturing Organization) Services
Table 52. Key Industry Trends of Biologics CMO (Contract Manufacturing Organization) Services
Table 53. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size Forecast by Region (2027-2032) & ($ millions)
Table 54. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share Forecast by Region (2027-2032)
Table 55. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size Forecast by Type (2027-2032) & ($ millions)
Table 56. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size Forecast by Application (2027-2032) & ($ millions)
Table 57. Lonza Group AG Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 58. Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 59. Lonza Group AG Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Lonza Group AG Main Business
Table 61. Lonza Group AG Latest Developments
Table 62. Samsung Biologics Co., Ltd. Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 63. Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 64. Samsung Biologics Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Samsung Biologics Co., Ltd. Main Business
Table 66. Samsung Biologics Co., Ltd. Latest Developments
Table 67. FUJIFILM Biotechnologies Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 68. FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 69. FUJIFILM Biotechnologies Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. FUJIFILM Biotechnologies Main Business
Table 71. FUJIFILM Biotechnologies Latest Developments
Table 72. Boehringer Ingelheim BioXcellence Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 73. Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 74. Boehringer Ingelheim BioXcellence Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Boehringer Ingelheim BioXcellence Main Business
Table 76. Boehringer Ingelheim BioXcellence Latest Developments
Table 77. WuXi Biologics (Cayman) Inc. Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 78. WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 79. WuXi Biologics (Cayman) Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. WuXi Biologics (Cayman) Inc. Main Business
Table 81. WuXi Biologics (Cayman) Inc. Latest Developments
Table 82. Thermo Fisher Scientific – Patheon Pharma Services Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 83. Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 84. Thermo Fisher Scientific – Patheon Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Thermo Fisher Scientific – Patheon Pharma Services Main Business
Table 86. Thermo Fisher Scientific – Patheon Pharma Services Latest Developments
Table 87. Catalent, Inc. Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 88. Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 89. Catalent, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Catalent, Inc. Main Business
Table 91. Catalent, Inc. Latest Developments
Table 92. AGC Biologics Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 93. AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 94. AGC Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. AGC Biologics Main Business
Table 96. AGC Biologics Latest Developments
Table 97. National Resilience, Inc. Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 98. National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 99. National Resilience, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. National Resilience, Inc. Main Business
Table 101. National Resilience, Inc. Latest Developments
Table 102. Vetter Pharma International GmbH Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 103. Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 104. Vetter Pharma International GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Vetter Pharma International GmbH Main Business
Table 106. Vetter Pharma International GmbH Latest Developments
Table 107. Rentschler Biopharma SE Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 108. Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 109. Rentschler Biopharma SE Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Rentschler Biopharma SE Main Business
Table 111. Rentschler Biopharma SE Latest Developments
Table 112. KBI Biopharma, Inc. Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 113. KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 114. KBI Biopharma, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. KBI Biopharma, Inc. Main Business
Table 116. KBI Biopharma, Inc. Latest Developments
Table 117. LOTTE BIOLOGICS Co., Ltd. Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 118. LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 119. LOTTE BIOLOGICS Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. LOTTE BIOLOGICS Co., Ltd. Main Business
Table 121. LOTTE BIOLOGICS Co., Ltd. Latest Developments
Table 122. Pfizer CentreOne Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 123. Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 124. Pfizer CentreOne Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Pfizer CentreOne Main Business
Table 126. Pfizer CentreOne Latest Developments
Table 127. AbbVie Contract Manufacturing Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 128. AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 129. AbbVie Contract Manufacturing Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. AbbVie Contract Manufacturing Main Business
Table 131. AbbVie Contract Manufacturing Latest Developments
Table 132. Syngene International Limited Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 133. Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 134. Syngene International Limited Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. Syngene International Limited Main Business
Table 136. Syngene International Limited Latest Developments
Table 137. Avid Bioservices, Inc. Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 138. Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 139. Avid Bioservices, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. Avid Bioservices, Inc. Main Business
Table 141. Avid Bioservices, Inc. Latest Developments
Table 142. Recipharm Advanced Bio Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 143. Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 144. Recipharm Advanced Bio Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 145. Recipharm Advanced Bio Main Business
Table 146. Recipharm Advanced Bio Latest Developments
Table 147. Ajinomoto Bio-Pharma Services Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 148. Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 149. Ajinomoto Bio-Pharma Services Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 150. Ajinomoto Bio-Pharma Services Main Business
Table 151. Ajinomoto Bio-Pharma Services Latest Developments
Table 152. Wacker Biotech GmbH Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 153. Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 154. Wacker Biotech GmbH Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 155. Wacker Biotech GmbH Main Business
Table 156. Wacker Biotech GmbH Latest Developments
Table 157. Bora Biologics Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 158. Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 159. Bora Biologics Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 160. Bora Biologics Main Business
Table 161. Bora Biologics Latest Developments
Table 162. 3PBIOVIAN Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 163. 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 164. 3PBIOVIAN Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 165. 3PBIOVIAN Main Business
Table 166. 3PBIOVIAN Latest Developments
Table 167. Fareva Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 168. Fareva Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 169. Fareva Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 170. Fareva Main Business
Table 171. Fareva Latest Developments
Table 172. Aenova Group Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 173. Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 174. Aenova Group Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 175. Aenova Group Main Business
Table 176. Aenova Group Latest Developments
Table 177. Siegfried Holding AG Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 178. Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 179. Siegfried Holding AG Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 180. Siegfried Holding AG Main Business
Table 181. Siegfried Holding AG Latest Developments
Table 182. GenScript ProBio Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 183. GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 184. GenScript ProBio Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 185. GenScript ProBio Main Business
Table 186. GenScript ProBio Latest Developments
Table 187. Chime Biologics (Wuhan) Co., Ltd. Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 188. Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 189. Chime Biologics (Wuhan) Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 190. Chime Biologics (Wuhan) Co., Ltd. Main Business
Table 191. Chime Biologics (Wuhan) Co., Ltd. Latest Developments
Table 192. MabPlex International Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 193. MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 194. MabPlex International Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 195. MabPlex International Main Business
Table 196. MabPlex International Latest Developments
Table 197. Pharmaron Beijing Co., Ltd. Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 198. Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 199. Pharmaron Beijing Co., Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 200. Pharmaron Beijing Co., Ltd. Main Business
Table 201. Pharmaron Beijing Co., Ltd. Latest Developments
Table 202. Thousand Oaks Biologics Inc. Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 203. Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 204. Thousand Oaks Biologics Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 205. Thousand Oaks Biologics Inc. Main Business
Table 206. Thousand Oaks Biologics Inc. Latest Developments
Table 207. Cytovance Biologics, Inc. Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 208. Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 209. Cytovance Biologics, Inc. Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 210. Cytovance Biologics, Inc. Main Business
Table 211. Cytovance Biologics, Inc. Latest Developments
Table 212. Porton Pharma Solutions Ltd. Details, Company Type, Biologics CMO (Contract Manufacturing Organization) Services Area Served and Its Competitors
Table 213. Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Product Offered
Table 214. Porton Pharma Solutions Ltd. Biologics CMO (Contract Manufacturing Organization) Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 215. Porton Pharma Solutions Ltd. Main Business
Table 216. Porton Pharma Solutions Ltd. Latest Developments

List of Figures
Figure 1. Biologics CMO (Contract Manufacturing Organization) Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Biologics CMO (Contract Manufacturing Organization) Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Biologics CMO (Contract Manufacturing Organization) Services Sales Market Share by Country/Region (2025)
Figure 8. Biologics CMO (Contract Manufacturing Organization) Services Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Type in 2025
Figure 10. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by CMO Provider Type in 2025
Figure 11. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Manufacturing Stage in 2025
Figure 12. Biologics CMO (Contract Manufacturing Organization) Services in Large Pharmaceutical and Biopharmaceutical Companies
Figure 13. Global Biologics CMO (Contract Manufacturing Organization) Services Market: Large Pharmaceutical and Biopharmaceutical Companies (2021-2026) & ($ millions)
Figure 14. Biologics CMO (Contract Manufacturing Organization) Services in Small and Mid-sized Pharmaceutical and Biotechnology Companies
Figure 15. Global Biologics CMO (Contract Manufacturing Organization) Services Market: Small and Mid-sized Pharmaceutical and Biotechnology Companies (2021-2026) & ($ millions)
Figure 16. Biologics CMO (Contract Manufacturing Organization) Services in Others
Figure 17. Global Biologics CMO (Contract Manufacturing Organization) Services Market: Others (2021-2026) & ($ millions)
Figure 18. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Application in 2025
Figure 19. Global Biologics CMO (Contract Manufacturing Organization) Services Revenue Market Share by Player in 2025
Figure 20. Global Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Region (2021-2026)
Figure 21. Americas Biologics CMO (Contract Manufacturing Organization) Services Market Size 2021-2026 ($ millions)
Figure 22. APAC Biologics CMO (Contract Manufacturing Organization) Services Market Size 2021-2026 ($ millions)
Figure 23. Europe Biologics CMO (Contract Manufacturing Organization) Services Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Market Size 2021-2026 ($ millions)
Figure 25. Americas Biologics CMO (Contract Manufacturing Organization) Services Value Market Share by Country in 2025
Figure 26. United States Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Region in 2025
Figure 31. APAC Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Type (2021-2026)
Figure 32. APAC Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Application (2021-2026)
Figure 33. China Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 37. India Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Country in 2025
Figure 40. Europe Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Type (2021-2026)
Figure 41. Europe Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Application (2021-2026)
Figure 42. Germany Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 43. France Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Biologics CMO (Contract Manufacturing Organization) Services Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Biologics CMO (Contract Manufacturing Organization) Services Market Size 2027-2032 ($ millions)
Figure 56. APAC Biologics CMO (Contract Manufacturing Organization) Services Market Size 2027-2032 ($ millions)
Figure 57. Europe Biologics CMO (Contract Manufacturing Organization) Services Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Biologics CMO (Contract Manufacturing Organization) Services Market Size 2027-2032 ($ millions)
Figure 59. United States Biologics CMO (Contract Manufacturing Organization) Services Market Size 2027-2032 ($ millions)